U.S., July 2 -- ClinicalTrials.gov registry received information related to the study (NCT07677774) titled 'GPC3-Targeted PET/CT in Hepatocellular Carcinoma' on June 08.
Brief Summary: The objective of the study is to evaluate the diagnostic value of GPC3-targeted PET/CT in patients with suspected or histologically/clinically confirmed hepatocellular carcinoma, and to compare with 18F-FDG PET/CT.
Study Start Date: May 01
Study Type: INTERVENTIONAL
Condition:
Hepatocellular Carcinoma (HCC)
Glypican-3
GPC3-targeted PET/CT
Intervention:
DIAGNOSTIC_TEST: 18F-FDG PET/CT and GPC3-targeted PET/CT
Participants will receive a single intravenous injection of 18F-FDG and 68Ga-GPC3, and undergo PET/CT imaging within the specified time.
Recruit...